Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.520
+0.100 (4.13%)
At close: Aug 13, 2025, 4:00 PM
2.500
-0.020 (-0.79%)
Pre-market: Aug 14, 2025, 8:52 AM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.28 million as of August 14, 2025. Its market cap has increased by 64.97% in one year.
Market Cap
4.28M
Enterprise Value
-890.79K
1-Year Change
64.97%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.28M, a decrease of -95.27%. That is a compound annual growth rate of -47.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 4.11M | 6.77% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |